These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26340849)

  • 21. SKIN PIGMENTATION, CORNEAL AND LENS OPACITIES WITH PROLONGED CHLORPROMAZINE TREATMENT.
    MASSEY LW
    Can Med Assoc J; 1965 Jan; 92(4):186-7. PubMed ID: 14232196
    [No Abstract]   [Full Text] [Related]  

  • 22. Amlodipine associated hyperpigmentation.
    Erbagci Z
    Saudi Med J; 2004 Jan; 25(1):103-5. PubMed ID: 14758392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loxapine as an alternative to phenothiazines in a case of oculocutaneous skin pigmentation.
    Ewing DG; Einarson TR
    Am J Psychiatry; 1981 Dec; 138(12):1631-2. PubMed ID: 7304801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Light and electron microscopy of chlorpromazine-induced hyperpigmentation.
    Calheiros T; de Almeida HL; Jorge VM; de Almeida AL; Motta L
    J Cutan Pathol; 2020 Apr; 47(4):402-405. PubMed ID: 31714613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ocular side effects of chlorpromazine in a child.
    Geiger LA; Lesser LL
    JAMA; 1967 Nov; 202(9):916. PubMed ID: 6072668
    [No Abstract]   [Full Text] [Related]  

  • 26. Ocular (pigmentary) effects of psychotropic drugs.
    Appleton WS; Shader RI; DiMascio A
    Conn Med; 1970 Jan; 34(1):25-8. PubMed ID: 4903792
    [No Abstract]   [Full Text] [Related]  

  • 27. [Complications on the part of the eyes during employment of psychotropic drugs (review of the foreign literature)].
    Gol'dovskaia IL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(6):935-9. PubMed ID: 4905472
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of promazine and chlorpromazine metabolites on the cornea.
    Adams HR; Manian AA; Steenberg ML; Buckley JP
    Adv Biochem Psychopharmacol; 1974; 9(0):281-93. PubMed ID: 4836207
    [No Abstract]   [Full Text] [Related]  

  • 29. The prevalence of the ocular side effects of chlorpromazine in the Tuscaloosa Veterans Administration patient population.
    Alexander LJ; Bowerman L; Thompson LR
    J Am Optom Assoc; 1985 Nov; 56(11):872-6. PubMed ID: 4078212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chlorpromazine-induced corneal toxicity.
    Koh V; Khor WB; Lim L
    Arch Ophthalmol; 2012 Nov; 130(11):1409. PubMed ID: 23143440
    [No Abstract]   [Full Text] [Related]  

  • 31. SKIN PIGMENTATION AND CORNEAL AND LENS OPACITIES WITH PROLONGED CHLORPROMAZINE THERAPY.
    GREINER AC; BERRY K
    Can Med Assoc J; 1964 Mar; 90(11):663-5. PubMed ID: 14127375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chlorpromazine-induced lenticular opacity.
    Srinivasan K; Gopalakrishna M
    Indian J Pharmacol; 2020; 52(4):339-340. PubMed ID: 33078739
    [No Abstract]   [Full Text] [Related]  

  • 33. DERMATOLOGICAL AND OPHTHALMOLOGICAL CHANGES ASSOCIATED WITH PROLONGED CHLORPROMAZINE THERAPY.
    FELDMAN PE; FRIERSON BD
    Am J Psychiatry; 1964 Aug; 121():187-8. PubMed ID: 14194222
    [No Abstract]   [Full Text] [Related]  

  • 34. Severe Conjunctival Reaction Following Attempted Corneal Tattooing.
    Pradhan S; Das M; Panigrahi AK; Prajna NV
    JAMA Ophthalmol; 2015 Jul; 133(7):854-6. PubMed ID: 25928549
    [No Abstract]   [Full Text] [Related]  

  • 35. The brown forehead ring: a pattern of facial pigmentation.
    O'Brien TJ
    Australas J Dermatol; 1995 May; 36(2):87-9. PubMed ID: 7646395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reticulate Pigmentation with Systemic Manifestations in a Child.
    Duman N; Ersoy-Evans S; Gököz Ö
    Pediatr Dermatol; 2015; 32(6):871-2. PubMed ID: 26584697
    [No Abstract]   [Full Text] [Related]  

  • 37. Kerato-lenticular ocular deposits and visual impairment with prolonged chlorpromazine use: A case series.
    Gowda GS; Hegde A; Shanbhag V; Narayanaswamy JC; Jaisoorya TS
    Asian J Psychiatr; 2017 Feb; 25():188-190. PubMed ID: 28262147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pseudocyanosis: drug-induced skin hyperpigmentation can mimic cyanosis.
    Weatherald J; Marrie TJ
    Am J Med; 2008 May; 121(5):385-6. PubMed ID: 18456031
    [No Abstract]   [Full Text] [Related]  

  • 39. Negligible hepatotoxicity of chlorpromazine in long-term therapy.
    Weinreb M; Kraus V; Krausová J; Hudcová T
    Act Nerv Super (Praha); 1978 Dec; 20(4):280-1. PubMed ID: 735735
    [No Abstract]   [Full Text] [Related]  

  • 40. Chlorpromazine-induced cutaneous pigmentation--effect of replacement with clozapine.
    Lal S; Lal S
    J Psychiatry Neurosci; 2000 May; 25(3):281. PubMed ID: 10863889
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.